Center for Perinatal Biology, Department of Physiology and Pharmacology, Loma Linda Univ., School of Medicine, Loma Linda, CA 92350, USA.
Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1797-806. doi: 10.1152/ajpheart.00112.2010. Epub 2010 Mar 26.
In the developing fetus, cerebral artery (CA) contractility demonstrates significant functional differences from that of the adult. This may be a consequence of differential activities of alpha(1)-adrenergic receptor (alpha(1)-AR) subtypes. Thus we tested the hypothesis that maturational differences in adrenergic-mediated CA contractility are, in part, a consequence of differential expression and/or activities of alpha(1)-AR subtypes. In CA from fetal ( approximately 140 days) and nonpregnant adult sheep, we used wire myography and imaging, with simultaneous measurement of tension and intracellular Ca(2+) concentration (Ca(2+)), radioimmunoassay, and Western immunoblots to examine phenylephrine (Phe)-induced contractile responses. The alpha(1A)-AR antagonists (5-MU and WB-4101) completely inhibited Phe-induced contraction in adult but not fetal CA; however, Ca(2+) increase was reduced significantly in both age groups. The alpha(1D)-AR antagonist (BMY-7378) blocked both Phe-induced contractions and Ca(2+) responses to a significantly greater extent in adult compared with fetal CA. In both age groups, inhibition of alpha(1A)-AR and alpha(1B)-AR, but not alpha(1D)-AR, significantly reduced inositol 1,4,5-trisphosphate responses to Phe. Western immunoblots demonstrated that the alpha(1)-AR subtype expression was only approximately 20% in fetal CA compared with the adult. Moreover, in fetal CA, the alpha(1D)-AR was expressed significantly greater than the other two subtypes. Also, in fetal but not adult CA, Phe induced a significant increase in activated ERK1/2; this increase in phosphorylated ERK was blocked by alpha(1B)-AR (CEC) and alpha(1D)-AR (BMY-7378) inhibitors, but not by alpha(1A)-AR inhibitors (5-MU or WB-4101). In conclusion, in the fetal CA, alpha(1B)-AR and alpha(1D)-AR subtypes play a key role in contractile response as well as in ERK activation. We speculate that in fetal CA alpha(1B)-AR and alpha(1D)-AR subtypes may be a critical factor associated with cerebrovascular growth and function.
在发育中的胎儿中,大脑动脉(CA)的收缩性表现出与成人显著不同的功能差异。这可能是由于 α1-肾上腺素能受体(α1-AR)亚型的不同活性所致。因此,我们假设,肾上腺素能介导的 CA 收缩性的成熟差异部分是由于 α1-AR 亚型的表达和/或活性的差异所致。我们使用线描记术和成像技术,同时测量张力和细胞内 Ca2+浓度([Ca2+]i),放射免疫测定和 Western 免疫印迹,检查了苯肾上腺素(Phe)诱导的收缩反应。α1A-AR 拮抗剂(5-MU 和 WB-4101)完全抑制了成人但不抑制胎儿 CA 中 Phe 诱导的收缩;然而,两种年龄组的[Ca2+]i 增加均显著降低。与胎儿 CA 相比,α1D-AR 拮抗剂(BMY-7378)更显著地阻断 Phe 诱导的收缩和 Ca2+反应。在两个年龄组中,抑制 α1A-AR 和 α1B-AR,但不是 α1D-AR,可显著减少 Phe 引起的三磷酸肌醇反应。Western 免疫印迹显示,α1-AR 亚型的表达在胎儿 CA 中仅约为成人的 20%。此外,在胎儿 CA 中,α1D-AR 的表达显著高于其他两种亚型。此外,在胎儿 CA 中,但在成人 CA 中,Phe 诱导 ERK1/2 的显著增加;磷酸化 ERK 的这种增加被 α1B-AR(CEC)和 α1D-AR(BMY-7378)抑制剂阻断,但不受 α1A-AR 抑制剂(5-MU 或 WB-4101)的阻断。总之,在胎儿 CA 中,α1B-AR 和 α1D-AR 亚型在收缩反应以及 ERK 激活中起关键作用。我们推测,在胎儿 CA 中,α1B-AR 和 α1D-AR 亚型可能是与脑血管生长和功能相关的关键因素。